Comparison of VOD rates between prophylaxis groups
. | Overall (n=488) . | MRD (n=202) . | MUD/MM (n=286) . | |||
---|---|---|---|---|---|---|
VOD incidence (n, %)* | Odds ratio to reference | VOD incidence (n, %)† | Odds ratio to reference | VOD incidence (n, %)‡ | Odds ratio to reference | |
Tac/Mtx | 16 (7) | 5 (4) | 11 (11) | |||
Tac/Sir/Mtx | 28 (21) | 3.23 (1.61-6.69, P < .001) | 2 (20) | 5.51 (0.46-41.2, P = .19) | 26 (21) | 2.05 (0.92-4.88, P = .09) |
Tac/Sir | 15 (11) | 1.55 (0.69-3.48, P = .33) | 8 (11) | 2.72 (0.75-11.0, P = .15) | 7 (16) | 1.01 (0.31-3.05, P > .99) |
. | Overall (n=488) . | MRD (n=202) . | MUD/MM (n=286) . | |||
---|---|---|---|---|---|---|
VOD incidence (n, %)* | Odds ratio to reference | VOD incidence (n, %)† | Odds ratio to reference | VOD incidence (n, %)‡ | Odds ratio to reference | |
Tac/Mtx | 16 (7) | 5 (4) | 11 (11) | |||
Tac/Sir/Mtx | 28 (21) | 3.23 (1.61-6.69, P < .001) | 2 (20) | 5.51 (0.46-41.2, P = .19) | 26 (21) | 2.05 (0.92-4.88, P = .09) |
Tac/Sir | 15 (11) | 1.55 (0.69-3.48, P = .33) | 8 (11) | 2.72 (0.75-11.0, P = .15) | 7 (16) | 1.01 (0.31-3.05, P > .99) |